Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
Drug resistance is the main obstacle to achieving a cure in many cancer patients. Reactive oxygen species (ROS) are master regulators of cancer development that act through complex mechanisms. Remarkably, ROS levels and antioxidant content are typically higher in drug-resistant cancer cells than in...
Main Authors: | Xiaoting Zhou, Biao An, Yi Lin, Yanghong Ni, Xia Zhao, Xiao Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223008260 |
Similar Items
-
Curcumin Induces Apoptosis of Chemoresistant Lung Cancer Cells via ROS-Regulated p38 MAPK Phosphorylation
by: Ming-Fang Wu, et al.
Published: (2022-07-01) -
Monogenic Disorders of ROS Production and the Primary Anti-Oxidative Defense
by: Nana-Maria Grüning, et al.
Published: (2024-02-01) -
A new triphenylphosphonium-conjugated amphipathic cationic peptide with improved cell-penetrating and ROS-targeting properties
by: Rezeda A. Ishkaeva, et al.
Published: (2023-01-01) -
The role of redox-mediated lysosomal dysfunction and therapeutic strategies
by: Xiaomeng He, et al.
Published: (2023-09-01) -
The Complex Interplay between Mitochondria, ROS and Entire Cellular Metabolism
by: Andrey V. Kuznetsov, et al.
Published: (2022-10-01)